Your browser doesn't support javascript.
loading
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy.
Schoenmakers, Daphne H; Beerepoot, Shanice; Krägeloh-Mann, Ingeborg; Elgün, Saskia; Bender, Benjamin; van der Knaap, Marjo S; Wolf, Nicole I; Groeschel, Samuel.
Afiliação
  • Schoenmakers DH; Department of Child Neurology, Amsterdam Leukodystrophy Center, Amsterdam UMC location Vrije Universiteit Amsterdam, Emma's Children's Hospital, Boelelaan 1117, Amsterdam, The Netherlands.
  • Beerepoot S; Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands.
  • Krägeloh-Mann I; Department of Endocrinology and Metabolism, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Elgün S; Department of Child Neurology, Amsterdam Leukodystrophy Center, Amsterdam UMC location Vrije Universiteit Amsterdam, Emma's Children's Hospital, Boelelaan 1117, Amsterdam, The Netherlands.
  • Bender B; Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands.
  • van der Knaap MS; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Wolf NI; Pediatric Transplant Center, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Groeschel S; Department of Child Neurology and Developmental Medicine, University Children's Hospital Tübingen, Hoppe-Seyler-Straße 1, 72076, Tübingen, Germany.
Ann Clin Transl Neurol ; 9(12): 1999-2009, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36334091
ABSTRACT

OBJECTIVES:

Metachromatic leukodystrophy (MLD) has characteristic white matter (WM) changes on brain MRI, which often trigger biochemical and genetic confirmation of the diagnosis. In early or pre-symptomatic disease stages, these typical MRI changes might be absent, hampering early diagnosis. This study aims to describe the characteristics of MRI WM abnormalities at diagnosis, related to clinical presentation.

METHODS:

We retrospectively reviewed brain MRIs of MLD patients followed in 2 centers at the time of diagnosis regarding MLD MRI score and presence of tigroid pattern. In addition, MLD subtype, symptom status, CNS/PNS phenotype, motor/cognitive/mixed phenotype, and the presence of CNS symptoms were evaluated.

RESULTS:

We included 104 brain MRIs from patients with late-infantile (n = 43), early-juvenile (n = 24), late-juvenile (n = 20) and adult (n = 17) onset. Involvement of the corpus callosum was a characteristic early MRI sign and was present in 71% of the symptomatic late-infantile patients, 94% of the symptomatic early-juvenile patients and 100% of the symptomatic late-juvenile and adult patients. Symptomatic early-juvenile, late-juvenile and adult patients generally had WM abnormalities on MRI suggestive of MLD. By contrast, 47% of the early-symptomatic late-infantile patients had no or only mild WM abnormalities on MRI, even in the presence of CNS symptoms including pyramidal signs.

INTERPRETATION:

Patients with late-infantile MLD may have no or only mild, nonspecific abnormalities at brain MRI, partly suggestive of 'delayed myelination', even with clear clinical symptoms. This may lead to significant diagnostic delay. Knowledge of these early MRI signs (or their absence) is important for fast diagnosis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article